June 25, 2021 09:31 ET | Source: ReportLinker ReportLinker

New York, June 25, 2021 (GLOBE NEWSWIRE) - Reportlinker.com announced the release of the "Global Central Venous Catheter (CVC) Industry" report-https://www.reportlinker.com/p05899197/?utm_source=GNW 1Expected It will be 1 billion in 2020, and the revised scale will reach 1.6 billion U.S. dollars in 2027, growing at a compound annual growth rate of 5.4% during the analysis period from 2020 to 2027. One of the market segments analyzed in the report, Duo Lumen, is expected to grow at a compound annual growth rate of 6.1% at the end of the analysis period, reaching USD 793.9 million. After an early analysis of the business impact of the pandemic and the economic crisis it triggered, the growth of the three-lumen segment was re-adjusted to a revised 5.2 percent compound annual growth rate over the next 7 years. This segment currently accounts for 28.2% of the global central venous catheter (CVC) market. -The United States accounted for more than 34.2% of the global market in 2020, while China is expected to have a compound annual growth rate of 7.1% during 2020-2027.-The US central venous catheter (CVC) market is estimated to be 388.2 US dollars in 2020 and 1 million. The country’s current share of the global market is 34.17%. China is the world's second-largest economy, and its market size is expected to reach US$192 million by 2027, with a compound annual growth rate of 7.1% by 2027. Other notable geographic markets include Japan and Canada, which are expected to grow by 4.3% and 4.5% respectively during 2020-2027. In Europe, Germany is expected to grow at a compound annual growth rate of approximately 4.8%, while other European markets (as defined in the study) will reach US$192 million by 2027. -The share of the dual-lumen market segment in 2020 is 17.7%-In the global dual-lumen market segment, the United States, Canada, Japan, China and Europe will drive the expected 4.5% compound annual growth rate of this segment. The total market size of these regional markets in 2020 is 159.1 million U.S. dollars, and by the end of the analysis period, the estimated size will reach 215.9 million U.S. dollars. China will remain one of the fastest growing countries in this regional market cluster. Led by countries such as Australia, India, and South Korea, the Asia-Pacific market is expected to reach US$173 million by 2027, while Latin America will grow at a compound annual growth rate of 5.3% during the analysis period. -Choose a competitor (61 selections in total)

Read the full report: https://www.reportlinker.com/p05899197/?utm_source=GNW Content I. Method II. Executive Summary 1. Market overview The impact of the 2020 COVID-19 pandemic and the imminent global recession is marked as a year of disruption and transformation Chart 1: World economic growth forecast from 2020 to 2022 (real GDP, annual percentage change) The pandemic has interrupted the operation of medical equipment and the supplies industry. Roller coaster in the elective surgery report of COVID-19 Annex 2: COVID-19 has led to a year-on-year decline in the number of heart operations in the United States in 2020. COVID-19 has led to a large backlog of elective surgeries and prolonged waiting time. (CVC) Is the central venous catheter still a key element for COVID-19 patients? Therapeutic Central Venous Catheter (CVC): The contradiction and complications of CVC, an indispensable medical device in the healthcare field. Global market outlook and outlook for central venous catheter types. Chart 3: 2020E Multi-lumen global central venous catheter market is designed by product type (%) Leading the CVC market with antimicrobial coated catheters witnessing high-growth hospitals: the largest end-use category developing economies take the lead in long-term growth, competing world brands, recent market activities 2. Focus on selecting participants 3. Market trends and driving factors The incidence of chronic diseases is rising Disease needs Central venous access drives the demand for CVC Chart 4: Global cancer incidence: The number of new cancer cases in 2018, 2020, 2025, 2030, 2035 and 2040 (millions) Chart 5: World diabetes and demographics (2030 Figure 6: Global prevalence of end-stage renal disease: the number of end-stage renal disease patients treated per million population in selected countries in 2019. Figure 7: Global annual CVD medical costs (unit: US$1 billion): In 2010, 2015, 2020, 2025 and 2030, the aging population is more sensitive to age-related chronic diseases to drive market growth. Figure 8: Global aging demographic data for the age group over 65 (unit: million) by geographic region Breakdown of 2019, 2025, 2035 and 2050 Chart 9: Seniors (over 65 years old) as a percentage of the total population by developed, underdeveloped and least developed regions: 2019 and 2030 Chart 10: 60-year-old expectations Lifespan and 80 years: (2010-2015), (2020-2025) and (2045-2050) The use of central venous catheters for chemotherapy to promote market growth Catheters play a vital role in the delivery of drugs and fluids in cancer treatment Dialysis: Potential growth of the CVC market Exhibit 11: Global dialysis patient population breakdown by geographic region/country (2019 and 2024) Catheter-related issues during hemodialysis Infection due to hygienic procedures reduces the amount of translumbar insertion surgery used by Percutan for alternate venous access for dialysis COVID-19 ARDS patients and the transition to minimally invasive surgery: a significant impact on the CVC market Figure 12: Global surgery volume by category ( In millions): 2019 Chart 13: Increasing number of surgeries in the United States (2010-2020) and 2001-2010 (%) Chart 14: Number of surgeries in selected countries (per 100,000 people) Central venous catheter: in Parenteral nutrition plays a key role in intravenous catheters in drug management. Increased use of central venous catheters in ICU environments. Increasing use of antibacterial dipping catheters. Advanced CVC is expected to bring better results for interventional procedures. 3M Korea One Integrated PICC/CVC Safety System CV D. A clear correlation between risk and central vein. Intravenous catheterization calls for minimizing catheter use. Continued growth in global healthcare expenditures drives e market opportunities Chart 15: World healthcare expenditures in 2017, 2019, 2021 and 2023 (in terms of (In trillions of dollars) Figure 16: Healthcare expenditures for the elderly in the United States, Europe, and Japan as a percentage of GDP in 1970, 2050, and 2050. Challenges facing the central venous catheter market 4. Global market outlook Table 1: By geographic region Central venous catheter (CVC) world status and future analysis-US, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa markets​​-Annual sales (in thousands of US dollars) from 2020 to 2027 Independent analysis and% CAGR Table 2: A review of the world history of central venous catheters (CVC) by geographic region-US, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa markets-2012 to 2019 Independent analysis of sales (in thousands of US dollars) and% CAGR Table 3: Central Venous Catheter (CVC) World 15-year Outlook by Geographic Region-Percentage Breakdown in 2012, 2020 and 2027 United States, Canada, Japan, China, Table of Value Sales in Europe, Asia Pacific, Latin America, Middle East and Africa Market 4: Current and Future Analysis of the Multi-lumen World by Geographic Region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa Markets- Independent analysis and% CAGR of annual sales (in thousands of US dollars) from 2020 to 2027 Table 5: Multi-lumen world history review regions by region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East And African markets-independent analysis of 2012-2019 annual sales (in thousands of US dollars) and compound annual growth rate percentage Table 6: World 15-year outlook for multiple lumens by geographic region-2012, 2020 and 2027 Breakdown of Sales Value Percentage Percentage in the United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East, and Africa in 2015 Table 7: World Current and Future Analysis Used for Three Lumens by Geographic Region-United States, Canada, Japan, China na, Europe, Asia Pacific, Latin America, Middle East and Africa markets-independent analysis and% CAGR of annual sales (in thousands of U.S. dollars) from 2020 to 2027 Table 8: Three-lumen world history review by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa markets-2012 to 2019 annual sales (in thousands of US dollars) independent analysis and% CAGR Table 9: Three-lumen world 15-year outlook by geography Regions-2012, 2020 and 2027 U.S., Canada, Japan, China, Europe, Asia Pacific, Latin America Continent, Middle East, and Africa’s sales value percentage breakdown Table 10: Current and future analysis of the world of double lumens by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa markets-for 2020 to Independent analysis of annual sales (in thousands of U.S. dollars) and compound annual growth rate percentage in 2027 Table 11: World History Review Used for double lumens by geographic region-U South Africa, Canada, Japan, China, Europe, Asia Pacific, Latin America Americas, Middle East, and Africa Markets-Independent Analysis and% CAGR of Annual Sales (Thousands of USD) from 2012 to 2019 Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa’s sales value percentage breakdown Table 13: World current and future single analysis-Lumens by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East, and Africa Markets-Independent Analysis and% CAGR of Annual Sales (Thousands of USD) from 2020 to 2027 Asia-Pacific, Latin America, Middle East and Africa markets-independent analysis of 2012-2019 annual sales (in thousands of US dollars) and% CAGR Table 15: Shan Lu's 15-year outlook for men by geographic region-2012, 2020 And 2027 United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa sales value percentage breakdown Table 16: Antimicrobial coatings not divided by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa markets-independent analysis of annual sales (in thousands of US dollars) from 2020 to 2027 and% CAGR Table 17: Historical review of the world's non-antimicrobial coatings by geographic region-United States , Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa Markets-Independent analysis and percentage compound annual growth rate of annual sales (in thousands of US dollars) from 2012 to 2019 Table 18: By geographic region 15-year World Non-Antimicrobial Coating Outlook-2012 and 2020 US, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa sales breakdown percentage & 2027 Table 19: World currencies by geographic region Antimicrobial coating rental and future analysis-US, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa markets-Independent analysis and percentage CAGR table of annual sales (in thousands of US dollars) from 2020 to 2027 20: A review of the world history of antimicrobial coatings by geographic region-US, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa markets-201 Independent analysis of annual sales in thousands of US dollars from 2 to 2012 in 2019 and% CAGR Table 21: 15-year World Antimicrobial Coating Outlook by Geographic Region-2012 United States, Canada, Japan, China, Europe, Asia Pacific, Percentage breakdown of sales value in Latin America, the Middle East, and Africa, 2020 and 2027 Table 22: Current Status and Future Analysis of the World's Jugular Veins by Geographic Region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East And African markets-independent analysis of annual sales (in thousands of US dollars) 2020 to 2027 and% CAGR Table 23: Review of the world history of the jugular vein by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America Americas, Middle East and Africa Markets-Independent Analysis of Annual Sales in Thousands of USD and% CAGR from 2012 to 2019 Table 24: 15 Years of Jugular Perspective in the World by Geographic Region-United States, Canada, Japan, China, Europe, Asia Pacific Percentage breakdown of sales value by region, Latin America, and the Middle East East and Africa in 2012, 2020, and 2027 Table 25: World Current and Future Femoral Vein Analysis by Geographic Region-United States, Canada, Japan, China, Europe , Asia Pacific, Latin America, Middle East and Africa markets-independent analysis of annual sales (thousand dollars) and% CAGR from 2020 to 2027 , Europe, Asia-Pacific, Latin America, Middle East and Africa markets-independent analysis of annual production. 2012 to 2019 sales (thousand dollars) and% CAGR Table 27: Femoral veins by geographic region in the world in 15 years-United States, Canada, Sales breakdown percentages in Japan, China, Europe, Asia Pacific, and Latin America in 2012, 2020 and 2027 United States, Middle East and Africa Table 28: World status and future analysis of the subclavian vein by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa Markets-An independent analysis of annual sales (in thousands of US dollars) and compound annual growth percentage from 2020 to 2027 Table 29: Subclavian vein by geographic region World History Review-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa Markets-Independent analysis and% CAGR of annual sales (in thousands of US dollars) from 2012 to 2019 Table 30: World 15 Subclavian Veins by Geographical Regions-Percentage Breakdown of Sales Value in the United States, Canada, Japan, China, Europe, Asia Pacific, 2012, 2020, and 2027 Latin America, Middle East, and Africa Table 31: World Hospitals by Geographic Region Status and future analysis-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America Continent, Middle East and Africa Market-Independent Analysis of Annual Sales (Thousands of USD) and Compound Annual Growth Rate Percentage from 2020 to 2027. Table 32: Hospital World History Review by Geographic Region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa Markets​​-Independent analysis and% CAGR of sales (in thousands of US dollars) from 2012 to 2019 Table 33: World's 15-year hospital outlook by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa in 2012, 2020 and 2027 Table 34: Current and future analysis of the world by other end-uses by geographic region-United States, Canada, Japan, China, Europe, Asia Pacific, Latin America, United States, Middle East and Africa Markets-Independent Analysis of Annual Sales in Thousands of U.S. Dollars and Compound Annual Growth Rate Percentage from 2020 to 2027 Table 35: World History Review of Other End Uses by Geographic Region-United States , Canada, Japan, China, Europe, Asia Pacific, Latin America, Middle East and East Africa-Independent analysis and% CAGR of annual sales (in thousands of US dollars) from 2012 to 2019 Table 36: Other end-uses by geographic region World’s 15-year Outlook-Percentage breakdown of sales value in the United States, Canada and Japan, China, Europe, Asia Pacific, Latin America, Middle East and Africa 2012, 2020 and 2027 III. Market Analysis United States Table 37: US Central Venous Catheter (CVC) ) Current and future analysis of designs-multi-lumen, triple-lumen, dual-lumen and single-lumen-independent analysis of annual sales (in thousands of dollars) over the years 2020 to 2027 and% CAGR Table 38: Central venous catheters designed in the United States (CVC) Historical Review-Multi-cavity, Three-cavity, Double-cavity and Single-cavity Markets-Independent analysis of annual sales in thousands of US dollars over the years 2012 to 2019 and% CAGR Table 39: United States 15 years by design The prospects of central venous catheters (CVC)-2012 multi-lumen, three-lumen, double-lumen, and single-lumen value sales percentages, 2020 and 2027 Table 40: Current and future analysis of central venous catheters (CVC) in the United States (by attribute) -Non-antibacterial coatings and antibacterial coatings-Independent analysis of annual sales (thousand dollars) and compound annual growth percentage from 2020 to 2027. Table 41: Central American Historical Review of Venous Catheters (CVC) by Attribute-Non Antimicrobial Coating and Antimicrobial Coating Market-Independent Analysis of Annual Sales (Thousands of USD) and Compound Annual Growth Rate Percentage from 2012 to 2019 Table 42: Central Venous Catheter (CVC) Outlook Attributes in the United States in 15 Years-2012, 2020 and Percentage of sales of non-antibacterial coatings and antibacterial coatings in 2027 Table 43: US Central Venous Catheter (CVC) by Current and future analysis of applications-jugular vein, femoral vein, and subclavian vein-independent analysis of annual sales (in thousands of dollars) and compound annual growth percentage from 2020 to 2027 Table 44: Central veins by application in the United States Historical Review of Catheter (CVC)-Jugular Vein, Femoral Vein and Subclavian Vein Market-Independent Analysis of Annual Sales in Thousands of USD and% CAGR from 2012 to 2019 CVC) Outlook-Percentage breakdown of Jugula sales value r Veins, femoral veins and subclavian veins in 2012, 2020 and 2027 And future analysis-independent analysis of US annual sales in thousands of dollars and% CAGR from 2020 to 2027 Table 47: Historical review of US central venous catheters (CVC) by end use-hospitals and other end-use markets-2012 to Independent analysis of annual sales in thousands of US dollars in 2012 for 2019 and% CAGR Table 48: U.S. 15-year central venous catheter (CVC) outlook by end use-Hospital and other end-use sales value in 2012, 2020 and 2027 Percentage Canada Table 49: Future analysis of current central venous catheter (CVC) designs in Canada-multi-lumen, triple-lumen, dual-lumen and single-lumen-independent analysis of annual sales (in thousands of US dollars) and% CAGR from 2020 to 2027 in Table 50 : Canadian Central Venous Catheter History Review (C VC) by design-multi-lumen, three-lumen, double-lumen and single-lumen markets-independent analysis table 51 of 2012-2019 annual sales (thousand dollars) and compound annual growth rate percentage : Canada's 15-year outlook for central venous catheters (CVC) by design breakdown-2012, 2020 and 2027 multi-lumen, triple-lumen, double-lumen and single-lumen sales value breakdown percentage Table 52: Canadian central venous catheter (CVC) ) Current and future analysis) by characteristics-non-antibacterial coatings and antibacterial coatings-independent analysis of annual sales (thousands of US dollars) and compound annual growth percentage from 2020 to 2027 Table 53: Canada's central venous catheter ( CVC) historical review (by characteristics)-non-antibacterial coating and antibacterial coating market-2012 to 2019 independent analysis of annual sales (in thousands of US dollars) and compound annual growth rate percentage Table 54: Canada 15 years by Prospects of Central Venous Catheter (CVC) by Property-Percentage of non-ant sales value breakdown by imicrobial and antimicrobial coatings in 2012, 2020 and 2027 Table 55: Current Central Venous Catheter (CVC) by Application in Canada And future analysis-jugular vein, femoral vein and lock Subosseous Vein-Independent Analysis of Annual Sales (in thousands of US dollars) 2020 to 2027 and% CAGR Table 56: Historical Review of Central Venous Catheter (CVC) in Canada by Application-Jugular Vein, Femoral Vein and Subclavian Venous market-independent analysis and percentage CAGR of annual sales (in thousands of US dollars) from 2012 to 2019 Subclavian Vein Value Sales Percentage Table 58: Canadian Current and Future Analysis Central Venous Catheter (CVC) by End Use-Hospitals and Other End Uses-Annual Sales (Thousands of USD) and Compound Annual Growth from 2020 to 2027 Independent Analysis of Rate Percentage Table 59: Oric Review of Central Venous Catheter (CVC) Classified by End Use in Canadian History-Hospitals and Other End Use Markets-2012-2019 Annual Sales (Thousands of USD) and Compound Annual Growth Rate Percentage Independent analysis table 60: 15-year outlook for central venous catheters in Canada. Catheters (CVC) by end-use segmentation-Percentage breakdown of sales value of Japanese hospitals and other end-uses in 2012, 2020, and 2027 Table 61: Japan by design versus center Current and future analysis of venous catheters (CVC)-multi-lumen, three-lumen, double-lumen and single-lumen-independent analysis of annual sales (thousand dollars) and compound annual growth percentage from 2020 to 2027 Table 62: Japanese central venous catheter (CVC) Design History Review-Multi-lumen, three-lumen, double-lumen and single-lumen markets-independent analysis of sales (thousand dollars) and compound annual growth percentage from 2012 to 2019 Table 63: Central Veins Designed in Japan in 15 Years Catheter (CVC) Outlook-Multi-L’s sales value percentage breakdown in 2012, 2020, and 2027. Umen, three-lumen, two-lumen, and single-lumen tables 64: Current and future analysis of Japanese central venous catheters (CVC) by characteristics -Non-antibacterial coatings and antibacterial coatings-Independent analysis of annual sales (in thousands of US dollars) and compound annual growth rate percentages from 2020 to 2027 Table 65: Historical review of central venous catheters (CVC) by property in Japan -Non-antibacterial coating and antibacterial coating market-Independent analysis of annual sales in thousands of US dollars from 2012 to 2019 and% CAGR Table 66: Japan's 15-year central venous catheter (CVC) outlook by asset classification-2012, Percentage sales of non-antibacterial and antibacterial coatings in 2020 and 2027 Table 67: Current and future analysis of central venous catheters (CVC) by application in Japan-jugular vein, femoral vein and subclavian vein-for 2020 Annual sales to 2027 ( Independent analysis of AGR in thousands of U.S. dollars) and% C Table 68: Review of the history of central venous catheter (CVC) applications in Japan-Jugular vein, femoral vein and subclavian vein market-for 2012 to 2019 annual sales (in thousands of U.S. dollars) And% CAGR independent analysis Table 69: Japan 15-Central Venous Catheter (CVC) by Application Years Outlook-Jugular Vein, Femoral Vein and Subclavian Vein Value Percentage of Sales in 2012, 2020 and 2027 Table 70: Japan Center Current and future analysis of venous catheters (CVC) end use-hospitals and other end uses-independent analysis of annual sales (thousand dollars) and compound annual growth percentage from 2020 to 2027 Table 71: Japan by end use classification Central Venous Catheter (CVC) History Review-Hospitals and other end-use markets-Independent analysis of sales (in thousands of US dollars) from 2012 to 2019 and% CAGR Table 72: Central Venous Catheters in Japan by End Use in 15 Years (CVC) Prospects-Percentage breakdown of sales value in China’s hospitals and other end-uses in 2012, 2020 and 2027. Table 73: Current status and future analysis of China’s central venous catheter (CVC) design-multi-lumen, three-lumen, double-lumen and Single Lumen-Independent Analysis of Annual Sales (Thousands of USD) and Compound Annual Growth Rate Percentage from 2020 to 2027 Lumen Market-2012-2019 Annual Sales (Thousands of US Dollars) and Compound Annual Growth Rate Percentage of Independent Analysis Table 75: Prospects of Central Venous Catheter (CVC) Designed in China in 15 Years-Value Sales of Multi-lumen, Three-lumen, and Double-Stream Percentage breakdown-Lumen and single lumen tables for 2012, 2020 and 2027 76: Current and future analysis of China's central venous catheters (CVC) (by attributes)-Non-antibacterial coatings and antibacterial coatings-Independent analysis of annual sales ( In thousands of US dollars) 2020 to 2027 and% compound annual growth rate Table 77: China's historical review of central venous catheters (CVC) (by assets)-non-antibacterial coating and antibacterial coating market-for 2012 to 2019 Independent analysis of annual sales (thousand dollars) and percentage compound annual growth rate Table 78: China's 15-year central venous catheter (CVC) prospects by asset classification-non-antibacterial and antibacterial coatings in 2012, 2020 and 2027 Percentage of sales value breakdown Table 79: Central Venous Catheter (CVC) Analysis of Current and Future Applications in China-Jugular Vein, Femoral Vein and Subclavian Vein-Annual Sales (Thousands of USD) and Compound Annual Growth Rate from 2020 to 2027 Independent Analysis of Percentage Table 80: Chinese Central Venous Catheter (CVC) History Review by Application-Jugular Vein, Femoral Vein and Lock Subosseous Venous Vein Market-Independent Analysis of Annual Sales (Thousands of USD) and Compound Annual Growth Rate Percentage from 2012 to 2019 Table 81: China's 15-year Central Venous Catheter (CVC) Outlook (by Appl) ication-2012, Percentage of Value Sales of Jugular Vein, Femoral Vein and Subclavian Vein in 2020 and 2027 Table 82: Current and Future Analysis of Central Venous Catheter (CVC) in China by End Use-Hospital and Other End Use-2020 to 2027 Independent Analysis of Annual Sales and Compound Annual Growth Rate Percentages in Thousands of USD Table 83: Historical Review of Central Venous Catheter (CVC) by End Use in China-Hospitals and Other End Use Markets-Independent Analysis of Annual Sales 2012 Thousands of US dollars and% CAGR from 2019 to 2019 Table 84: China's 15-year central venous catheter (CVC) outlook by end use-Percentage of sales value of hospitals and other end uses in 2012 and 2020 & 2027 EUROPE Table 85: Europe Current and future analysis of central venous catheters (CVC) by geographic region-France, Germany, Italy, UK, Spain, Russia and other European markets-Independent analysis of annual sales in thousands of US dollars over the years 2020-2027 and % CAGR Table 86: European Central Venous Catheter (CVC) History by Geographical Region-France, Germany, Italy, UK, Spain, Russia and other European markets-Independent analysis of annual sales in thousands of US dollars in 2012 2019 and% CAGR Table 87: Europe's 15-year central venous catheter (CVC) prospects by geographic region-2012 France, Germany, Italy, the United Kingdom, Spain, Russia and the rest of Europe market sales value percentage breakdown, 2020 Year and 2027 Table 88: Current and Future Analysis of European Central Venous Catheter (CVC) Design-Multi-lumen, Triple-lumen, Double-lumen and Single-lumen-Independent analysis of annual sales (in thousands of US dollars) for 2020 to 2027 And% CAGR Table 89: European Central Venous Catheter (CVC) Design History Review-Multi-lumen, Three-lumen, Double-Lumen and Single-lumen Markets-Independent analysis of annual sales in thousands of US dollars from 2012 to 2019 and% CAGR Table 90: Europe's 15-year Central Venous Catheter (CVC) Outlook by Design-2012, 2020 and 2027 Multi-lumen, Three-lumen, Double-lumen and Single-lumen Value Sales Percentage Table 91: European Current and Attribute-based Central Venous Catheter (CVC) Analysis of the future-non-antibacterial coatings and antibacterial coatings-independent analysis of annual sales (in thousands of US dollars) and compound annual growth percentage from 2020 to 2027 Table 92: European Central Venous Catheter (CV) C) Historical review) By asset-Non-antibacterial coating and antibacterial coating market-Independent analysis of sales (in thousands of US dollars) from 2012 to 2019 and% CAGR Table 93: Central vein by asset classification in Europe in 15 years Catheter (CVC) Outlook-Breakdown Percentage of Sales Value of Non-Antibacterial Coatings and Antibacterial Coatings in 2012, 2020 and 2027 Table 94: Current and Future Analysis of Central Venous Catheter (CVC) Applications in Europe-Jugular Vein, Femoral Vein and Clavicle Inferior vein-independent analysis of annual sales (thousand dollars) and compound annual growth percentage from 2020 to 2027. Table 95: European Central Venous Catheter (CVC) Application History Review-Jugular Vein, Femoral Vein and Subclavian Vein Market-2012 Independent analysis of sales (thousand dollars) and compound annual growth percentage from year to 2019. Table 96: European 15-year central venous catheter (CVC) application prospects-the value of the jugular vein, femoral vein and subclavian vein sales percentage breakdown Table 97 for 2012, 2020 and 2027: Current and future analysis of central venous catheters (CVC) by end use in Europe-hospitals and other end uses-independent analysis of annual sales (in thousands of US dollars) from 2020 to 2027 And% CAGR Table 98: European Central Venous Catheter (CVC) by End Use Historical Review-Hospitals and Other End Use Markets-Independent Analysis of Annual Sales in Thousands of U.S. Dollars from 2012 to 2019 and% CAGR Table 99: Europe 15-year outlook for central venous catheters (CVC) by end use-Percentage breakdown of sales value of hospitals and other end-uses in 2012, 2020 and 2027 France Table 100: Current and future analysis of central venous catheters (CVC) by design in France- Multi-lumen, three-lumen, double-lumen and single-lumen-independent analysis of annual sales (thousand dollars) and% CAGR from 2020 to 2027 Dual-lumen and single-lumen markets-2012-2019 annual sales (in thousands of US dollars) and% CAGR independent analysis table 102: France 15-annual outlook for central venous catheters (CVC) by design-multi-lumen, three-lumen sales Percentage breakdown by value, read the full report: https://www.reportlinker.com/p05899197/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so that you can get all the market research you need instantly in one place. __________________________